Leukemia, Myeloid, Acute

Showing NaN - NaN of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Oral Azacitidine
  • Placebo
  • Phoenix, Arizona
  • +247 more
Jan 13, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • San Francisco, California
  • +25 more
Jan 9, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • New Haven, Connecticut
  • +94 more
Jun 9, 2022

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

Recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Houston, Texas
  • +5 more
May 31, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • H3B-8800 (RVT-2001)
  • Stanford, California
  • +26 more
Mar 23, 2022

Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Marina Del Rey, California
  • +35 more
Mar 11, 2022

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (Cytarabine, Idasanutlin, Placebo)

Terminated
  • Leukemia, Myeloid, Acute
  • Great Neck, New York
  • +81 more
Dec 28, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (Cobimetinib, Idasanutlin, Venetoclax)

Completed
  • Leukemia, Myeloid, Acute
  • Los Angeles, California
  • +16 more
Dec 13, 2021

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (Placebo, Volasertib, Cytarabine)

Completed
  • Leukemia, Myeloid, Acute
  • Placebo
  • +2 more
  • Los Angeles, California
  • +121 more
Oct 25, 2021

Leukemia, Myeloid, Acute Trial in Spain, United States (JNJ-63709178)

Completed
  • Leukemia, Myeloid, Acute
  • Detroit, Michigan
  • +9 more
Aug 30, 2021

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)

Terminated
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Boston, Massachusetts
  • +5 more
Jun 11, 2021

Leukemia, Myeloid, Acute Trial in Australia, Korea, Republic of, United States (NLA101, Standard of Care (SOC) chemo)

Terminated
  • Leukemia, Myeloid, Acute
  • NLA101
  • Standard of Care (SOC) chemotherapy
  • La Jolla, California
  • +35 more
Mar 25, 2021

Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)

Completed
  • Leukemia, Myeloid, Acute
  • SGI-110 (guadecitabine)
  • Treatment Choice
  • Scottsdale, Arizona
  • +134 more
Dec 21, 2020

Leukemia, Myeloid, Acute Trial in Worldwide (AC220)

Completed
  • Leukemia, Myeloid, Acute
  • Los Angeles, California
  • +23 more
Dec 20, 2019

Leukemia, Myeloid, Acute Trial in Canada, United States (DCLL9718S, Azacitidine)

Completed
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +7 more
Nov 18, 2019

Leukemia, Myeloid, Acute Trial in Germany, United States (BAY1436032)

Completed
  • Leukemia, Myeloid, Acute
  • Bronx, New York
  • +12 more
May 13, 2019

Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine 20 mg/m^2, Talacotuzumab 9 mg/kg)

Completed
  • Leukemia, Myeloid, Acute
  • Decitabine 20 mg/m^2
  • Talacotuzumab 9 mg/kg
  • Orange, California
  • +80 more
Mar 11, 2019

Leukemia, Myeloid, Acute Trial in United States (AC220, daunorubicin, cytarabine)

Completed
  • Leukemia, Myeloid, Acute
  • Jacksonville, Florida
  • +4 more
Feb 8, 2019